For the quarter ending 2025-09-30, VYCO has $941,195 in assets. $4,965,388 in debts. $64,230 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 64,230 | 99,700 | ||
| Trade accounts receivable, net | 326,052 | 202,669 | ||
| Inventory, net | 167,415 | 156,033 | ||
| Prepaid expenses and other current assets | 103,474 | 95,690 | ||
| Current assets of discontinued operations | 1,425 | 263 | ||
| Total current assets | 662,596 | 554,355 | ||
| Fixed assets, net | 148,474 | 164,338 | ||
| Non-current inventory | 56,510 | 74,460 | ||
| Security deposits | 6,000 | 6,000 | ||
| Operating lease - right of use assets | 67,615 | 79,793 | ||
| Total other assets | 130,125 | 160,253 | ||
| Total assets | 941,195 | 878,946 | ||
| Accounts payable | 92,821 | 110,042 | ||
| Accrued interest-Nonrelated Party | 556,932 | 544,833 | ||
| Accrued interest-Related Party | 233,108 | 235,537 | ||
| Accrued liabilities | 127,231 | - | ||
| Dividends payable - related party-Related Party | 2,919,330 | 2,757,145 | ||
| Notes payable-Nonrelated Party | 340,939 | 303,074 | ||
| Notes payable-Related Party | 493,373 | 493,373 | ||
| Accrued liabilities-Nonrelated Party | - | 88,429 | ||
| Current operating lease liabilities | 51,179 | 50,157 | ||
| Current liabilities of discontinued operations | 164 | -1,051 | ||
| Total current liabilities | 4,815,077 | 4,581,539 | ||
| Operating lease liability - long term | 13,566 | 26,700 | ||
| Loan payable - sba eidl | 136,745 | 137,651 | ||
| Total liabilities | 4,965,388 | 4,745,890 | ||
| Preferred stock, value-Series DPreferred Stock | 27 | 27 | ||
| Preferred stock, value-Series CPreferred Stock | - | 0 | ||
| Common stock, 0.0001 par value, 55,000,000 shares authorized at september 30, 2025 and december 31, 2024 33,476,130 shares issued and 33,372,796 shares outstanding at september 30, 2025 and december 31, 2024, respectively | 3,347 | 3,347 | ||
| Additional paid-in capital | 29,431,959 | 29,431,959 | ||
| Treasury stock (103,334 shares of common stock as at september 30, 2025 and december 31, 2024, at cost) | 1,033 | 1,033 | ||
| Accumulated deficit | -33,586,170 | -33,428,921 | ||
| Accumulated other comprehensive income | 127,677 | 127,677 | ||
| Total stockholders deficiency | -4,024,193 | -3,866,944 | ||
| Total liabilities and stockholders deficiency | 941,195 | 878,946 | ||
VYCOR MEDICAL INC (VYCO)
VYCOR MEDICAL INC (VYCO)